B. Vaughan Hudson - Concepedia

Author

B. Vaughan Hudson

North Middlesex Hospital

Also Known As

B Vaughan Hudson, B. V. Hudson, B. Vaughan Hudson, B.Vaughan Hudson, Bryan Vaughan Hudson, G. Vaughan Hudson

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

North Middlesex Hospital Mount Vernon Hospital University College London Middlesex Hospital Royal Marsden NHS Foundation Trust

About

B. Vaughan Hudson is an author at North Middlesex Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.3K
2	Health Sciences	3	3	244
3	Epidemiology	2	2	115
4	Public Health	1	1	34
5	Allergy	1	1	52

B. Vaughan Hudson

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study ME Hill, KA MacLennan, David Cunningham, Blood	1996	311
Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Anthony J. Swerdlow, A. J. Douglas, G. Vaughan Hudson, BMJ	1992	244
REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX J. L. Haybittle, M.J. Easterling, MR Bennett, The Lancet Lymphoid NeoplasiaMedicineImmunodeficienciesSurgical PathologyDiagnosis	1985	183
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy B. Vaughan Hudson, G. Vaughan Hudson, KA MacLennan, British Journal of Cancer Lymphoid NeoplasiaSurgical OncologyLong-term Follow-upHealth SciencesRadiation Therapy	1994	175
Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients Kenneth MacLennan, Michael H. Bennett, Anna Tu, Cancer Nodular SclerosingDisease ProgressionImmunologyPathologyDermatology	1989	166
Non-Hodgkin's lymphoma of the testis A. Crellin, B. Vaughan Hudson, M.H. Bennett, Radiotherapy and Oncology Lymphoid NeoplasiaHistopathologyDiagnosisPathologyLymphatic Disease	1993	114
Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: A 20-year experience MR Bennett, K.A. MacLennan, G. Vaughan Hudson, Annals of Oncology Lymphoid Neoplasia20-Year ExperienceMedicinePathologyLymphoma Arising	1991	104
The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: An analysis of 271 non-laparotomised cases (BNLI report no. 22) M.H. Bennett, K.A. MacLennan, M.J. Easterling, Clinical Radiology Lymphoid NeoplasiaSurgical PathologyHistopathologyImmunologyPathology	1983	89
Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy AJ Douglas, G. Vaughan Hudson, B. Vaughan Hudson, British Journal of Cancer Lymphoid NeoplasiaSurgical OncologyEpidemiologyMedicineSurgical Pathology	1993	81
The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non‐intensive therapy by the British National Lymphoma Investigation Group Elisabeth Vandenberghe, Chris De Wolf‐Peeters, G. Vaughan Hudson, British Journal of Haematology	1997	74

Page 1